Etanercept response and IL-10 promoter genotypes.

Data represent relative risk / 95% confidence interval of therapy response subject to carriage of distinct alleles or haplotypes. In the study population, 25 patients responded well, and 25 patients moderately or not.Etanercept response and IL-10 promoter genotypes.本数据集展示了携带不同等位基因（allele）或单体型（haplotype）时，治疗应答的相对风险与95%置信区间。本研究队列共纳入50例患者，其中25例治疗应答良好，剩余25例应答中等或无应答。本数据集聚焦依那西普（Etanercept）治疗应答与IL-10启动子基因型的关联数据。